Steve Ruchefsky

Berklee Trustee; Executive Chairman of MDSolarSciences

Steve Ruchefsky has been an active private investor, both as principal and as investment manager, since 2000. Until recently, he served as the senior executive and private investment manager for the founder and chief executive officer of a multibillion-dollar hedge fund and, as such, was responsible for the initial funding of many successful businesses and ventures, including Cougar Biotechnology, Inc., later acquired by Johnson & Johnson; and Ziopharm Oncology, Inc. In addition, Ruchefsky was an early investor and founding director of Kite Pharma, Inc., acquired by Gilead Sciences, Inc. in October 2017 for $11.9 billion. Prior to this, he served on Kite’s audit, compensation, and nominating committees.
 He's currently executive chairman of MDSolarSciences and a board member of Arno Therapeutics, Inc.

A graduate of the George Washington University Law School, Ruchefsky began his professional career at the New York City law firm  Morrison Cohen, where he ultimately became a partner, a member of the management committee, and the chair of a specialized litigation group. He's the founder and president of Resilience Music Alliance, an independent music label dedicated to releasing culturally diverse, world-class recordings that recognize, celebrate, and challenge the human condition of resilience. Over the years, he has served on the board of the Westport Country Playhouse, a nationally recognized regional theatre, and executive produced the award-winning documentary film No Place on Earth. He's currently the producer of the theatrical production War Stories: A Veterans Project.

While primarily residing in Westport, Connecticut, Ruchefsky can also be found in New York City, New York, and Malibu, California, with his wife Rondi Charleston, a Julliard-trained jazz vocalist and Emmy Award–winning journalist. Their daughter Emma is a professional music major and voice principal at Berklee.